Earlier this year, health insurance giant Aetna was left broken-hearted when its $37 billion merger with Humana fell through because federal antitrust regulators apparently hate to see two mammoth insurers so in love with each other. But in this autumn season, there’s a rare bloom of corporate romance peeking out, as Aetna has reportedly found itself a suitor in the form of CVS Health. [More]
prescription drugs
FDA Cracking Down On “Rogue Online Pharmacies” Accused Of Illegally Selling Prescription Drugs
By 9.25.17
While you may be tempted to skip the pharmacy and just order prescription drugs online, it could be very dangerous to use any unapproved medications from illicit online pharmacies. That’s why the U.S. Food and Drug Administration — along with its international enforcement superfriends — is taking action against hundreds of sites accused of selling prescription drugs illegally online. [More]
Many Insurance Plans Cover Opioid Painkillers But Restrict Access To Less-Addictive Drugs
By 9.18.17
With an opioid addiction epidemic ravaging the nation, physicians are being asked to consider non-opioid treatments or opioids that are less addictive than the widely abused drugs on the market. But there’s a big problem with that suggestion: Many insurance companies won’t cover, or heavily restrict access to, a number of less-addictive painkillers. [More]
Doctors Call On Big Pharma To Advertise Retail Prices Of Prescription Drugs
By 6.16.17
Think of the last prescription you had filled: You probably know how much you had to pay the pharmacy, but do you have any idea of the full sticker price for that medication? With many drug prices soaring, the nation’s largest physicians organization has called on the pharmaceuticals industry to be more transparent about the sometimes huge price tags on their products. [More]
New Safety Risks Found In 1-In-3 Drugs After FDA Approval
By 5.10.17
No one wants patients to have to wait longer for access to potentially lifesaving new drugs, and the newly approved head of the Food and Drug Administration has made it clear that he intends to speed up current approval processes when possible. However, a new study says safety risks were found in around one-third of all new FDA-approved medications after they had been okayed for use by the agency. [More]
EpiPen Maker Mylan Sued State That Gave Preferred Status To Cheaper Alternative
By 4.24.17
As the price for the EpiPen emergency allergy treatment soared by some 600%, Medicaid regulators in one state tried to de-prioritize the drug in favor of a less-expensive alternative. EpiPen’s parent company Mylan could have lowered the price on its signature product, but instead it chose to sue the state. [More]
EpiPen Maker Mylan Accused Of Raising Price To Pay “Kickbacks” To Pharmacy Benefit Managers
By 4.4.17 — Updated: 5.9.17
The EpiPen emergency allergy treatment was pushed into the spotlight last year over concerns about its skyrocketing price and the lack of any real competition for a product that had been around for decades. A new federal lawsuit alleges that Mylan — the company that acquired EpiPen ten years ago — raised its prices in order to provide bigger kickbacks to the companies that help determine which drugs your insurer will and won’t cover. [More]
CVS Selling Generic Alternative To EpiPen For Fraction Of The Price
By 1.12.17
Until the recent launch of the generic EpiPen, the only affordable competitor available to the emergency allergy treatment was Adrenaclick, but that drug was hard to find and some pharmacies charged nearly as much as they did for EpiPen. Now CVS says it is selling two-packs of an authorized generic of Adrenaclick at about one-sixth of the price tag for brand-name EpiPen. [More]
Pharmacists Will Hand Over Drug Combinations That Could Kill You About Half The Time
By 12.19.16
Most chain pharmacies want you to feel safe ordering from them, and so their ads tout the skill, expertise, and personal touch of their tools and personnel. They promise available pharmacists who have computers who alert them to danger, and who can then tell you things like, “Hey, you shouldn’t take these together; it will kill you” if there’s a problem. [More]
Bristol-Myers Squibb Agrees To Pay $19.5M Over Improper Marketing Of Medication
By 12.8.16 — Updated: 12.12.16
Prescription medication, when used properly and safely, can provide needed relief to consumers suffering a wide range of illnesses or physical conditions. However, those medications must be marketed and advertised properly. That apparently wasn’t the case for a antipsychotic prescription drug manufactured Bristol-Myers Squibb (BMS). As a result, the company has agreed to pay $19.5 million in a settlement with 42 states and the District of Columbia. [More]
After Confusion Over EpiPen Profits, Lawmakers Want Proof Of Drug’s Actual Costs
By 10.3.16
When Mylan CEO Heather Bresch recently testified before the House Oversight Committee, she claimed that the company only made $50 per EpiPen, in spite of charging $608 per two-pack of the emergency allergy medicine. Mylan then said it makes around $80/EpiPen — a figure that lawmakers still doubted. Now the leadership of the Oversight Committee is asking Mylan to clear things up for everyone by turning over documents that actually show how much the company makes from EpiPen. [More]
One Free Meal From A Pharma Sales Rep May Be Enough To Change Doctors’ Prescribing Habits
By 6.23.16
Your physician may have any number of degrees, honors, certifications, and other framed pieces of paper mounted to their office walls, but does any of that make them less susceptible to a glad-handing pharmaceutical sales rep who comes armed with some reading materials, free samples, and a lunch charged to their expense account? [More]
5 Reasons Prescription Drug Prices Are Going Up For Many Americans
By 6.21.16
If you feel like you’re paying more for medication, you’re not alone. A new investigation from our colleagues at Consumer Reports finds that one-third of Americans are seeing higher prices for prescriptions, and one-in-six people chose to avoid getting a prescription filled because of the cost. So what’s behind the increased cost of staying well? [More]
How Well Do You Know The Real Names Of The Drugs You Take?
June 9, 2016
Ads for prescription and over-the-counter drugs are everywhere, so much so that we’ve become accustomed to hearing and seeing the brand name of a medication immediately followed by a parenthetical containing the generic name [ex: Valtrex (valacyclovir)], but how well have we been paying attention to these ads? Are we now so savvy that we immediately know that Chantix is the trade name for varenicline, or have we become so inured to these ads that we aren’t paying any attention? [More]
Drug Companies Subpoenaed Over Questionable Charity Connections
By 5.27.16
Whenever there is a report of a drug company jacking up the price of a prescription medication, the pharma industry is often quick to point out that there are non-profit charities ready and willing to help patients get these drugs at a more affordable rate. However, those charities may have very close ties to the drug maker that could not only help the company turn a profit, but avoid some tax obligations. In recent months, several large pharmaceutical companies have been subpoenaed as part of an ongoing federal investigation into these connections. [More]
Health Insurers Looking To Pay Less When Drugs Don’t Work As Advertised
By 5.11.16
If a drug maker says their new prescription medication will reduce cholesterol by a certain percentage, or that it will counter symptoms of some chronic illness, but it doesn’t quite live up to its marketing, should the insurance companies still pay the price they originally agreed to? A growing number of insurers are making deals that tie the price of a drug to its real-world performance. [More]
New Warning Labels Coming To Opioid Painkillers
By 3.22.16
A week after the Centers for Disease Control and Prevention called on physicians to stop prescribing opioid painkillers when less-problematic therapeutic treatments will do the trick, another federal agency is joining in the effort to alert consumers to the potential risks of using these frequently prescribed medications. [More]
Martin Shkreli Pleads The Fifth To Everything, Even When Asked About Wu-Tang Clan
By 2.4.16
Like a small child who refuses to eat his dinner but remains steadfast at his seat until his parents finally relent and let him go to his room, controversial pharmaceuticals investor Martin Shkreli — best known for jacking up the price of an important HIV treatment by 5,400% in a single day — sat before a Congressional panel this morning and repeatedly cited his Fifth Amendment right against self-incrimination, even when it involved his expensive taste in hip-hop. [More]
